Skip to main content
SpringerLink
Log in

Worldwide Burden of Gynecological Cancer

  • Reference work entry
Handbook of Disease Burdens and Quality of Life Measures

Abstract:

Cancer incidence, mortality, and prevalence are commonly used indicators of cancer burden. Estimation of cancer burden is valuable for the formulation of cancer control policies and planning health services. The sources and methods of estimation of global data and the worldwide burden of gynecological cancers (malignant neoplasm of uterine cervix, corpus, ovary, vagina, vulva, and placenta) are described. Cervical cancer accounted for 487,300 new cases and 269,500 deaths; uterine corpus cancer for 233,300 new cases and 61,400 deaths; ovarian cancer for 230,000 new cases and 140,100 deaths; cancers of the vagina, vulva, placenta, and ill-defined sites together constituted 74,900 cases. Less developed countries accounted for more than 80% of the cervical cancer cases while almost 60% of uterine corpus cases occurred in the developed world. Earnest implementation of current developments in screening and vaccination has the potential to dramatically reduce the burden of cervical cancer. The differences in the outcome of cancer treatment across the world are due to vast disparities in health service infrastructures, human resources, service delivery, and accessibility to services. A significant proportion of patients are unable to access and avail or complete preventive, diagnostic, and therapy services in many countries due to inadequate health care services and financing. Formulation and translation of appropriate cancer control policies and investments in awareness creation, human resources development, and healthcare infrastructure are vital to reduce the current burden of gynecological cancer in low- and medium-resource countries. On the other hand, attention should be focused on emerging cost-effective options to sustain and further improve current control prospects in the developed world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 3,000.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACCP:

Alliance for Cervical Cancer Prevention

ASR:

age-standardized rate

CIN:

cervical intraepithelial neoplasia

HPV:

human papillomavirus

IARC:

International Agency for Research on Cancer

ICD-10:

international statistical classification of diseases, 10th edition

NCCP:

National Cancer Control Programme

SEER:

Surveillance, Epidemiology and End Results Programme

TVS:

transvaginal sonography

VIA:

visual inspection with acetic acid

WHO:

World Health Organization

References

  • Agosti JM, Goldie SJ. (2007). N Engl J Med. 356: 1908–1910.

    Article  PubMed  CAS  Google Scholar 

  • Alliance for Cervical Cancer Prevention (ACCP). (2004). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. ACCP, Seattle.

    Google Scholar 

  • Altieri A, Franceschi S, Ferlay J, Smith J, La VC. (2003). Lancet Oncol. 4: 670–678.

    Article  PubMed  Google Scholar 

  • Arbyn M, Autier P, Ferlay J. (2007). Ann Oncol. 18: 1423–1425.

    Article  PubMed  CAS  Google Scholar 

  • Armstrong BK. (1992). Cancer Causes Control. 3: 569–579.

    Article  PubMed  CAS  Google Scholar 

  • Badgwell D, Bast RC Jr. (2007). Dis Markers. 23: 397–410.

    PubMed  CAS  Google Scholar 

  • Bosch FX, de Sanjose S. (2003). J Natl Cancer Inst Monogr. 31: 3–13.

    PubMed  Google Scholar 

  • Bray F, Dos Santos Silva I, Moller H, Weiderpass E. (2005). Cancer Epidemiol Biomarkers Prev. 14: 1132–1142.

    Article  PubMed  Google Scholar 

  • Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S. (2002). N Engl J Med. 346: 1105–1112.

    Article  PubMed  Google Scholar 

  • Chia KS, Du WB, Sankaranarayanan R, Sankila R, Seow A, Lee HP. (2001). Int J Cancer. 93: 142–147.

    Article  PubMed  CAS  Google Scholar 

  • Curado MP, Edwards B, Shin HR, Strom H, Ferlay J, Heanue M, Boyle P. (2007). Cancer Incidence in Five Continents, vol. 9. IARC Scientific Publications No. 160, IARC, Lyon.

    Google Scholar 

  • Denny L, Kuhn L, De Sousa M, Pollack AE, Dupree W, Wright TC Jr. (2005). JAMA. 294: 2173–2181.

    Article  PubMed  CAS  Google Scholar 

  • Ferlay J, Bray F, Pisani P, Parkin DM. (2004). GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 version 2.0. IARC, Lyon.

    Google Scholar 

  • Franco EL. (2003). J Natl Cancer Inst Monogr. 31: 89–96.

    PubMed  Google Scholar 

  • Franco EL, Ferenczy A. (2007). Future Oncol. 3: 319–327.

    Article  PubMed  Google Scholar 

  • Gondos A, Brenner H, Wabinga H, Parkin DM. (2005). Br J Cancer. 92: 1808–1812.

    Article  PubMed  CAS  Google Scholar 

  • Gondos A, Chokunonga E, Brenner H, Parkin DM, Sankila R, Borok MZ, Chirenje ZM, Nyakabau AM, Bassett MT. (2004). Int J Cancer. 112: 860–864.

    Article  PubMed  CAS  Google Scholar 

  • Gustafsson L, Ponten J, Bergstrom R, Adami HO. (1997). Int J Cancer. 71: 159–165.

    Article  PubMed  CAS  Google Scholar 

  • Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. (2006). Lancet. 367: 1247–1255.

    Article  PubMed  CAS  Google Scholar 

  • Herzog TJ, Monk BJ. (2007). Am J Obstet Gynecol. 197: 566–571.

    Article  PubMed  Google Scholar 

  • IARC. (2004). IARC Handbooks on Cancer Prevention, vol. 10: Cervix Cancer Screening. IARC, Lyon.

    Google Scholar 

  • IARC. (2007). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. vol. 90: Human Papillomaviruises. IARC, Lyon.

    Google Scholar 

  • Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. (2006). Obstet Gynecol. 107: 1018–1022.

    Article  PubMed  Google Scholar 

  • Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. (2007). Gynecol Oncol. 104: 232–246.

    Article  PubMed  Google Scholar 

  • Koutsky LA, Harper DM. (2006). Vaccine. 24: S114–S121.

    Article  Google Scholar 

  • Loukovaara M, Pukkala E, Lehtovirta P, Leminen A. (2004). Gynecol Oncol. 92: 252–255.

    Article  PubMed  Google Scholar 

  • Luo W, Morrison H, de Groh M, Waters C, DesMeules M, Jones-McLean E, Ugnat AM, Desjardins S, Lim M, Mao Y. (2007). Chronic Dis Can. 27: 135–144.

    PubMed  Google Scholar 

  • Marugame T, Hirabayashi Y. (2007). Jpn J Clin Oncol. 37: 802–803.

    Article  PubMed  Google Scholar 

  • Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. (2003). N Engl J Med. 348: 518–527.

    Article  PubMed  Google Scholar 

  • Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM. (2005). Int J Cancer. 116: 740–754.

    Article  PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P. (2005). CA Cancer J Clin. 55: 74–108.

    Article  PubMed  Google Scholar 

  • Parkin DM, Bray FI, Devesa SS. (2001). Eur J Cancer. 37: S4–S66.

    Article  PubMed  Google Scholar 

  • Pisani P, Bray F, Parkin DM. (2002). Int J Cancer. 97: 72–81.

    Article  PubMed  CAS  Google Scholar 

  • Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ. (2007). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. NIH Pub. No. 07–6215. NIH, Bethesda.

    Google Scholar 

  • Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J. (2007). Lancet. 370: 398–406.

    Article  PubMed  Google Scholar 

  • Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM, Chauhan MK, Desai S, Fontaniere B, Frappart L, Kothari A, Lucas E, Panse N. (2005). Int J Cancer. 116: 617–623.

    Article  PubMed  CAS  Google Scholar 

  • Sankaranarayanan R, Budukh AM, Rajkumar R. (2001). Bull World Health Organ. 79: 954–962.

    PubMed  CAS  Google Scholar 

  • Sankaranarayanan R, Black RJ, Parkin DM. (1998). Cancer Survival in Developing Countries. IARC Scientific Publications No 15. IARC, Lyon.

    Google Scholar 

  • Sankaranarayanan R, Swaminathan R, Black RJ. (1996). Cancer. 78: 2461–2464.

    Article  PubMed  CAS  Google Scholar 

  • Smith HO, Qualls CR, Prairie BA, Padilla LA, Rayburn WF, Key CR. (2003). Obstet Gynecol. 102: 978–987.

    Article  PubMed  Google Scholar 

  • Smith HO, Tiffany MF, Qualls CR, Key CR. (2000). Gynecol Oncol. 78: 97–105.

    Article  PubMed  CAS  Google Scholar 

  • Somoye G, Olaitan A, Mocroft A, Jacobs I. (2005). J Obstet Gynaecol. 25: 35–38.

    Article  PubMed  CAS  Google Scholar 

  • The EUROCARE Working Group. (2003). Ann Oncol. 14: v61–118.

    Google Scholar 

  • The Future II Study. (2007). N Engl J Med. 356: 1915–1927.

    Google Scholar 

  • United Nations. (2006). Population Division (http://www.un.org/). World Population Prospects (The 2006 revision).

  • Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. (1998). Int J Cancer. 75: 536–545.

    Article  PubMed  CAS  Google Scholar 

  • World Health Organization. (2002). National Cancer Control Programmes: Policies and Managerial Guidelines, 2nd ed. WHO, Geneva.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head, Screening Group, International Agency for Research on Cancer, Lyon, France

    R. Sankaranarayanan

  2. Descriptive Epidemiology, Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France

    J. Ferlay (Informatics Officer)

Authors
  1. R. Sankaranarayanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Ferlay
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Nutrition and Dietetics Nutritional Sciences Research Division School of Biomedical & Health Sciences, King's College London, Franklin‐Wilkins Building 150 Stamford Street, SE1 9NH, London, UK

    Victor R. Preedy (Prof.) (Prof.)

  2. Mel and Enid Zuckerman College of Public Health, University of Arizona, Health Science Center 1295 N. Martin, P.O. Box 245155, 85724-5155, Tucson, AZ

    Ronald R. Watson (Prof.) (Prof.)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media LLC

About this entry

Cite this entry

Sankaranarayanan, R., Ferlay, J. (2010). Worldwide Burden of Gynecological Cancer. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_46

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78665-0_46

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-78664-3

  • Online ISBN: 978-0-387-78665-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation